The Journal of Immunology, Vol 152, Issue 9 4242-4254, Copyright © 1994 by American Association of Immunologists

ARTICLES

Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age- related decline in CTL

ET Bloom and JA Horvath
Laboratory of Cellular Immunology, Food and Drug Administration, Bethesda, MD 20892.

The mechanism(s) by which IL-12 augments CTL generation and the potential for IL-12 to alter the age-related decline in CTL activity were assessed using primary CTL stimulated by allogeneic cells. IL-12 at 2 U/ml enhanced the generation of allospecific CTL response in young adult mice by 1.5- to 5-fold, and optimal augmentation was achieved and maintained with as low as 0.1 U/ml IL-12. In contrast to the enhancement of MHC-unrestricted lytic activity, which was most efficient when IL-12 was added near the end of the 5 day culture period, nearly equivalent augmentation of Ag-specific CTL was induced when IL-12 was added from 1 to 5 days before harvest. The augmentation of CTL by IL-12 was not associated with increased incorporation of [3H]TdR. Increased IFN-gamma production was not required for IL-12 to augment CTL activity because when three different Abs against mouse IFN- gamma were each included in the MLC at concentrations abolishing recoverable IFN-gamma protein, they did not inhibit the IL-12 effect but, under some conditions, further increased CTL activity. Ab to IL-2 also did not alter the IL-12 effect. Depletion of ASGM1+ cells from the responding population before stimulation did not significantly alter the response to IL-12. However, depletion of CD8+ T cells from effector cells obtained after stimulation substantially reduced the IL-12- induced augmentation of CTL. Thus, the results suggested that IL-12 augments CTL activity primarily through an effect on T cells, and the augmentation was associated with an approximate doubling of perforin levels, which was not caused by a significantly increased proportion of CD8+ cells. Finally, IL-12 was effective for moderating the age-related decrease in CTL activity, suggesting a potential role for immunomodulation by IL-12.

This article has been cited by other articles:

				M. N. Torrero, W. G. Henk, and S. Li Regression of High-Grade Malignancy in Mice by Bleomycin and Interleukin-12 Electrochemogenetherapy Clin. Cancer Res., January 1, 2006; 12(1): 257 - 263. [Abstract] [Full Text] [PDF]

				Y. Nishioka, H. Wen, K. Mitani, P. D. Robbins, M. T. Lotze, S. Sone, and H. Tahara Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells: a critical role for nitric oxide J. Leukoc. Biol., May 1, 2003; 73(5): 621 - 629. [Abstract] [Full Text] [PDF]

				B. Samten, B. Wizel, H. Shams, S. E. Weis, P. Klucar, S. Wu, R. Vankayalapati, E. K. Thomas, S. Okada, A. M. Krensky, et al. CD40 Ligand Trimer Enhances the Response of CD8+ T Cells to Mycobacterium tuberculosis J. Immunol., March 15, 2003; 170(6): 3180 - 3186. [Abstract] [Full Text] [PDF]

				M. Katae, Y. Miyahira, K. Takeda, H. Matsuda, H. Yagita, K. Okumura, T. Takeuchi, T. Kamiyama, A. Ohwada, Y. Fukuchi, et al. Coadministration of an Interleukin-12 Gene and a Trypanosoma cruzi Gene Improves Vaccine Efficacy Infect. Immun., September 1, 2002; 70(9): 4833 - 4840. [Abstract] [Full Text] [PDF]

				S. P. Li, Z. Cai, W. Shi, A. Brunmark, M. Jackson, and P.-J. Linton Early Antigen-Specific Response by Naive CD8 T Cells Is Not Altered with Aging J. Immunol., June 15, 2002; 168(12): 6120 - 6127. [Abstract] [Full Text] [PDF]

				M. Kelleher and P. C. L. Beverley Lipopolysaccharide Modulation of Dendritic Cells Is Insufficient to Mature Dendritic Cells to Generate CTLs from Naive Polyclonal CD8+ T Cells In Vitro, Whereas CD40 Ligation Is Essential J. Immunol., December 1, 2001; 167(11): 6247 - 6255. [Abstract] [Full Text] [PDF]

				A. V. Gorbachev, N. A. DiIulio, and R. L. Fairchild IL-12 Augments CD8+ T Cell Development for Contact Hypersensitivity Responses and Circumvents Anti-CD154 Antibody-Mediated Inhibition J. Immunol., July 1, 2001; 167(1): 156 - 162. [Abstract] [Full Text] [PDF]

				H. Ito, J. Kurtz, J. Shaffer, and M. Sykes CD4 T Cell-Mediated Alloresistance to Fully MHC-Mismatched Allogeneic Bone Marrow Engraftment Is Dependent on CD40-CD40 Ligand Interactions, and Lasting T Cell Tolerance Is Induced by Bone Marrow Transplantation with Initial Blockade of this Pathway J. Immunol., March 1, 2001; 166(5): 2970 - 2981. [Abstract] [Full Text] [PDF]

				I. Okamoto, K. Kohno, T. Tanimoto, K. Iwaki, T. Ishihara, S. Akamatsu, H. Ikegami, and M. Kurimoto IL-18 Prevents the Development of Chronic Graft-Versus-Host Disease in Mice J. Immunol., June 1, 2000; 164(11): 6067 - 6074. [Abstract] [Full Text] [PDF]

				L. Lefrancois, S. Olson, and D. Masopust A Critical Role for CD40-CD40 Ligand Interactions in Amplification of the Mucosal CD8 T Cell Response J. Exp. Med., November 1, 1999; 190(9): 1275 - 1284. [Abstract] [Full Text] [PDF]

				H. D. Lacorazza, J. A. Guevara Patino, M. E. Weksler, and D. Radu Failure of Rearranged TCR Transgenes to Prevent Age-Associated Thymic Involution J. Immunol., October 15, 1999; 163(8): 4262 - 4268. [Abstract] [Full Text] [PDF]

				A. E. Lukacher, J. M. Moser, A. Hadley, and J. D. Altman Visualization of Polyoma Virus-Specific CD8+ T Cells In Vivo During Infection and Tumor Rejection J. Immunol., September 15, 1999; 163(6): 3369 - 3378. [Abstract] [Full Text] [PDF]

				M. M. Gherardi, J. C. Ramirez, D. Rodriguez, J. R. Rodriguez, G.-I. Sano, F. Zavala, and M. Esteban IL-12 Delivery from Recombinant Vaccinia Virus Attenuates the Vector and Enhances the Cellular Immune Response Against HIV-1 Env in a Dose-Dependent Manner J. Immunol., June 1, 1999; 162(11): 6724 - 6733. [Abstract] [Full Text] [PDF]

				I. Okamoto, K. Kohno, T. Tanimoto, H. Ikegami, and M. Kurimoto Development of CD8+ Effector T Cells Is Differentially Regulated by IL-18 and IL-12 J. Immunol., March 15, 1999; 162(6): 3202 - 3211. [Abstract] [Full Text] [PDF]

				M. M. Nociari, W. Telford, and C. Russo Postthymic Development of CD28-CD8+ T Cell Subset: Age-Associated Expansion and Shift from Memory to Naive Phenotype J. Immunol., March 15, 1999; 162(6): 3327 - 3335. [Abstract] [Full Text] [PDF]

				J.-I. Sin, J. J. Kim, J. D. Boyer, R. B. Ciccarelli, T. J. Higgins, and D. B. Weiner In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model J. Virol., January 1, 1999; 73(1): 501 - 509. [Abstract] [Full Text] [PDF]

				E. J. McFarland, P. A. Harding, S. MaWhinney, R. T. Schooley, and D. R. Kuritzkes In Vitro Effects of IL-12 on HIV-1-Specific CTL Lines from HIV-1-Infected Children J. Immunol., July 1, 1998; 161(1): 513 - 519. [Abstract] [Full Text] [PDF]

				M. Marinaro, P. N. Boyaka, F. D. Finkelman, H. Kiyono, R. J. Jackson, E. Jirillo, and J. R. McGhee Oral but Not Parenteral Interleukin (IL)-12 Redirects T Helper 2 (Th2)-type Responses to an Oral Vaccine Without Altering Mucosal IgA Responses J. Exp. Med., February 3, 1997; 185(3): 415 - 428. [Abstract] [Full Text] [PDF]